Palvella Therapeutics, Inc.
PVLA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583648
In the last 90 days, Palvella Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 196 institutions reported holding it in 13F filings for Q2 2026, worth $2.15B in total; no superinvestor holds it.
Holders of 5% or more of PVLA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Palvella Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Kaupinen Wes | 13D | 14.60%1.64M shares | New | Dec 20, 20241 filing | Dec 20, 2024 | SEC |
| First Light Asset Management, LLC | 13G | 7.49%887.0K shares | New | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
| Suvretta Capital Management, LLC | 13G/A | 7.40%822.4K shares | −1.20 ppfrom 8.60% | Dec 20, 20242 filings | Nov 13, 2025 | SEC |
| Biotechnology Value Fund L P | 13G/A | 7.10%879.0K shares | −2.89 ppfrom 9.99% | Nov 14, 20252 filings | Feb 17, 2026 | SEC |
| Frazier Life Sciences Public Fund, L.P. | 13G/A | 6.00%706.4K shares | +1.10 ppfrom 4.90% | Jan 8, 20254 filings | Feb 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Palvella Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20264:34 PM ET | First Light Asset Management, LLCand 1 other | 13G | 7.49%887.0K shares | New | Dec 31, 2025 | SEC |
| Feb 17, 20264:21 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 7.10%879.0K shares | −2.89 ppfrom 9.99% | Dec 31, 2025 | SEC |
| Feb 13, 20265:33 PM ET | Frazier Life Sciences Public Fund, L.P.and 13 others | 13G/A | 6.00%706.4K shares | +1.10 ppfrom 4.90% | Dec 31, 2025 | SEC |
| Nov 14, 20254:19 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 9.99%1.18M shares | – | Sep 30, 2025 | SEC |
| Nov 13, 20255:31 PM ET | Suvretta Capital Management, LLCand 2 others | 13G/A | 7.40%822.4K shares | −1.20 ppfrom 8.60% | Sep 30, 2025 | SEC |
| Aug 14, 20255:26 PM ET | Samsara BioCapital, L.P.and 2 others | 13G/A | 3.10%339.7K shares | −3.00 ppfrom 6.10%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20251:41 PM ET | Frazier Life Sciences Public Fund, L.P.and 19 others | 13G/A | 4.90%545.5K shares | −1.40 ppfrom 6.30%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20259:39 AM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13G/A | 6.30%690.0K shares | +1.20 ppfrom 5.10% | Mar 31, 2025 | SEC |
| Jan 8, 20253:04 PM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13G | 5.10%575.9K shares | New | Dec 13, 2024 | SEC |
| Dec 20, 20245:32 PM ET | Kaupinen Wesand 4 others | 13D | 14.60%1.64M shares | New | Dec 13, 2024 | SEC |
| Dec 20, 20244:59 PM ET | Samsara BioCapital, L.P.and 2 others | 13G | 6.10%679.5K shares | New | Dec 13, 2024 | SEC |
| Dec 20, 20244:56 PM ET | Suvretta Capital Management, LLCand 2 others | 13G | 8.60%714.5K shares | New | Dec 13, 2024 | SEC |
| Dec 17, 20244:22 PM ET | Dellora Investments LPand 2 others | 13G/A | 1.30%141.1K shares | −9.40 ppfrom 10.70%Below 5% | Dec 13, 2024 | SEC |
| Dec 6, 20242:21 PM ET | Dellora Investments LPand 2 others | 13G/A | 10.70%141.1K shares | +2.40 ppfrom 8.30% | Nov 6, 2024 | SEC |
| Aug 7, 20242:16 PM ET | Dellora Investments LPand 2 others | 13G | 8.30%109.0K shares | New | Jul 24, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Palvella Therapeutics, Inc. shares.
No Form 144 notices for Palvella Therapeutics, Inc. are on file.